comparemela.com

Latest Breaking News On - Scopus biopharma - Page 4 : comparemela.com

Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors

Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors - read this article along with other careers information, tips and advice on BioSpace

Delaware
United-states
Jerusalem
Israel-general
Israel
Celgene-bristol-myers-squibb
Rodd-leeds-david-waldman
Scopus-biopharma
Joshuar-lamstein
Raphael-rafi-hofstein
Alan-horsager
Zealand-pharma

Scopus BioPharma Announces Biotechnology Industry Leader

Raphael (“Rafi”) Hofstein, Ph.D. Brings Invaluable Experience to Scopus BioPharma.

Delaware
United-states
Jerusalem
Israel-general
Israel
Celgene-bristol-myers-squibb
Scopus-biopharma
Joshuar-lamstein
Raphael-rafi-hofstein
Alan-horsager
Zealand-pharma
Department-of-neurobiology-at-harvard-medical-school

Scopus BioPharma Inc. (SCPS) Appoints Raphael Hofstein to its Board

Scopus BioPharma Inc. (SCPS) Appoints Raphael Hofstein to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Delaware
United-states
Jerusalem
Israel-general
Israel
Celgene-bristol-myers-squibb
Scopus-biopharma
Joshuar-lamstein
Raphael-rafi-hofstein
Alan-horsager
Zealand-pharma
Department-of-neurobiology-at-harvard-medical-school

Scopus BioPharma's Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies Summit

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United-states
Rodd-leeds-david-waldman
Scopus-biopharma
Alan-horsager
Company-form
Exchange-commission
Scopus-biopharma-inc
Crescendo-communications
Nasdaq
Chief-executive-officer
Bifunctional-approach
Targeting-therapies-summit

Scopus BioPharma's Subsidiary — Duet BioTherapeutics — to

Alan Horsager, Ph.D., President and Chief Executive Officer of Duet, to Present onTLR9 Activation and STAT3 Inhibition: A Bifunctional Approach to.

United-states
Rodd-leeds-david-waldman
Scopus-biopharma
Alan-horsager
Company-form
Exchange-commission
Scopus-biopharma-inc
Crescendo-communications
Nasdaq
Chief-executive-officer
Bifunctional-approach
Targeting-therapies-summit

vimarsana © 2020. All Rights Reserved.